TERRA and Telomere Maintenance in the Yeast Saccharomyces cerevisiae

Genes (Basel). 2023 Feb 28;14(3):618. doi: 10.3390/genes14030618.

Abstract

Telomeres are structures made of DNA, proteins and RNA found at the ends of eukaryotic linear chromosomes. These dynamic nucleoprotein structures protect chromosomal tips from end-to-end fusions, degradation, activation of damage checkpoints and erroneous DNA repair events. Telomeres were thought to be transcriptionally silent regions because of their constitutive heterochromatin signature until telomeric long non-coding RNAs (LncRNAs) were discovered. One of them, TERRA (TElomeric Repeat-containing RNA), starts in the subtelomeric regions towards the chromosome ends from different telomeres and has been extensively studied in many evolutionarily distant eukaryotes. Changes in TERRA's expression can lead to telomeric dysfunction, interfere with the replicative machinery and impact telomere length. TERRA also co-localizes in vivo with telomerase, and can form RNA:DNA hybrid structures called R-loops, which have been implicated in the onset of senescence and the alternative lengthening of telomere (ALT) pathway. Yet, the molecular mechanisms involving TERRA, as well as its function, remain elusive. Here, we review the current knowledge of TERRA transcription, structure, expression, regulation and its multiple telomeric and extra-telomeric functions in the budding yeast Saccharomyces cerevisiae.

Keywords: R-loops; Saccharomyces cerevisiae; TERRA; senescence; survivors; telomere maintenance.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heterochromatin
  • RNA, Long Noncoding* / metabolism
  • Saccharomyces cerevisiae* / genetics
  • Saccharomyces cerevisiae* / metabolism
  • Telomere / genetics
  • Telomere / metabolism
  • Transcription, Genetic

Substances

  • RNA, Long Noncoding
  • Heterochromatin

Grants and funding

M.T.T.’s laboratory was supported by the CNRS, Sorbonne University, the “Fondation de la Recherche Medicale” (“Equipe FRM EQU202003010428”), by the French National Research Agency (ANR) as part of the “Investissements d’Avenir” Program (LabEx Dynamo ANR-11-LABX-0011-01) and The French National Cancer Institute (INCa_15192). B.Z. is a recipient of fellowship from the «Ministère de l’Enseignement Supérieur et de la Recherche» (MESR).